Jim Cramer Discussed These 16 Stocks Recently

Page 2 of 15

14. ARS Pharmaceuticals, Inc. (NASDAQ:SPRY)

Number of Hedge Fund Holders: 34

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 16 stocks that Jim Cramer recently discussed. A caller asked if it was a good time to buy the stock. Cramer replied:

“You know what? I like their model… and I think that, well, here’s what I look at, it’s a great flier. Someone needs that technology, someone’s going to pay for it.”

ARS Pharmaceuticals (NASDAQ:SPRY) is a biopharmaceutical company focused on helping patients and caregivers manage severe allergic reactions, with its product neffy, a nasal epinephrine spray approved for emergency treatment of anaphylaxis in both the U.S. and EU.

In the first quarter of 2025, the company reported $8.0 million in total revenue. The net loss for the quarter was $33.9 million, or $0.35 per share. Moreover, as of March 31, ARS Pharmaceuticals (NASDAQ:SPRY) held $275.7 million in cash, cash equivalents, and short-term investments. It maintained its outlook that current financial resources are expected to support operations for at least the next three years.

Page 2 of 15